发现了针对SARS-CoV-2 Mpro的潜在抑制剂
1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. liyan@imb.pumc.edu.cn.
European review for medical and pharmacological sciences
|October 3, 2024
概括
研究人员使用高通量查确定了四种低毒性SARS-CoV-2 Mpro抑制剂. 化合物IMB63-8G显示出显著的抗病毒功效和有利的药物相似性,突出了其在COVID-19治疗中的治疗潜力.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行,由于缺乏特定治疗方法,造成了全球卫生危机.
- 抑制SARS-CoV-2主要蛋白酶 (Mpro) 对于防止病毒复制和传播至关重要.
研究的目的:
- 发现和描述SARS-CoV-2 Mpro.的新型抑制剂.
- 评估已识别的Mpro抑制剂的抗病毒活性和药物相似性.
主要方法:
- 使用光极化 (FP) 和光共振能量转移 (FRET) 试验的高通量选 (HTS).
- 使用SPR,HPLC-Q-TOF-MS,MTT和CPE试验进行抑制概况.
- 进行了分子对接和药物相似性分析.
主要成果:
- 确定了四种具有低毒性的非共价Mpro抑制剂.
- IMB63-8G对HCoV-OC43 (IC50 = 1.71μg/mL) 具有强大的抗病毒活性,具有高选择性 (SI = 39).
- IMB63-8G显示了有利的药物相似性特征.
结论:
- 已识别的化合物,特别是IMB63-8G,显示出治疗SARS-CoV-2感染的治疗潜力.
- 这些发现支持Mpro抑制剂作为抗病毒剂的进一步开发.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
4.6K
相关概念视频
Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
